Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Upgrades Dolby Laboratories (DLB) to Buy; Strong Q1 beat; Raises 2010 Guidance on Accelerating Broadcast
-
Canaccord Adams Reiterates a 'Buy' on Noble Energy (NBL); Another Good Quarter
-
Canaccord Adams Maintains a 'Buy' Rating on Oil States International (OIS); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Key Energy Services (KEG); Margins Disappoint But Due to Recover
-
Canaccord Adams Reinstates a 'Hold' Rating on Cenovus Energy (CVE); Revised Estimates & PT After Q1 Results
-
Canaccord Adams Comments on Metals and Mining -- Agriculture Stocks
-
Canaccord Adams Downgrades Axitron AG (AIXG) to Hold
-
Canaccord Adams maintains a 'Hold' on First Solar (FSLR); Leveraging Mix and Tight Macro, But Project Development Pressure Persists
-
Canaccord Adams Reiterates a 'Buy' on Green Mountain Coffee (GMCR); Margin Power Gets Hidden & Under-Appreciated
-
Canaccord Adams Reiterates a 'Buy' Rating on Life Sciences Stocks - ILMN, IMA & OFIX
-
Canaccord Adams Reiterates a 'Buy' on RightNow Technologies (RNOW); Solid Bookings Leave Outlook Positive Despite Foreign Exchange Dampener
-
Canaccord Adams Reiterates a 'Buy' on LogMeIn (LOGM); Third "At Risk" Quarter Strong; Solid Track Record Growing
-
Canaccord Adams Reiterates a 'Buy' on Epicor Software (EPIC); Solid Q1/10 After Strong Q4/09 Leaves Momentum Intact
-
Canaccord Adams Reiterates a 'Buy' on Xilinx (XLNX); Raises PT & Estimates
-
Canaccord Adams Maintains a 'Buy' on Internet Brands (INET); Better Guidance on Accelerating Audience Growth
-
Canaccord Adams Maintains a 'Buy' Rating on RPC, Inc. (RES); Raises PT on Blow Out Qtrly Results
-
Canaccord Adams Maintains a 'Buy/Best Idea' on Metalico (MEA); Buy Ahead of Q1 Earnings Report
-
Canaccord Adams Reiterates a 'Buy' on Volcano Corp (VOLC), Attractive Small-Cap Med-Tech Acquisition Candidate
-
Canaccord Adams Reiterates a 'Buy' on Seattle Genetics (SGEN); Don't Read Too Much Into Lintuzumab Phase II Delay
-
Canaccord Adams Reiterates a 'Buy' on AMAG Pharmaceuticals (AMAG); Disappointing Q1 Sales Mask Positive Demand Trends
-
Canaccord Adams Reiterates a 'Buy' on Ultimate Software (Nasdaq: ULTI); Beginning Year on a Positive Note
-
Canaccord Adams Reiterates a 'Buy' on National Oilwell Varco (NOV); Q1 Results iimpress, But Rig Tenders Delayed
-
RIM's (RIMM) New BlackBerry OS Impresses Some, Others Say Company Still Playing Catch Up
-
Canaccord Adams Reiterates a 'Buy' on Itron (ITRI); Playing Offense with OpenWay
-
Canaccord Adams Reiterates a 'Buy' on Alphatec (ATEC); Hosts Technology Day; Strong Differentiated Pipeline Should Reaccelerate Growth
-
Canaccord Adams Reiterates a 'Hold' on Zoran Corporation (ZRAN); Pricing Pressure/Inventory Adjustment Hamper Results
-
Canaccord Adams Reiterates a 'Buy' on Advanced Analogic Technologies (AATI); Uncertain Handset Trends Offset By TV Pipeline
-
Canaccord Adams Reiterates a 'Buy' on Volterra Semiconductor (VLTR); Strong Results & Guidance with Product Cycles Extending Visibility Into 2011
-
Canaccord Adams Reiterates a 'Buy' on Texas Instruments (TXN); Analog Products Drive Upside; 300mm Fab Poised to Drive Down Costs
-
Canaccord Adams Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA)
-
Canaccord Adams Reiterates a 'Buy' on Schlumberger (SLB); Q1 Results In Line; Bright Outlook Takes Spotlight
-
Canaccord Adams Maintains a 'Hold' on LSI Industries (LYTS); Updates Numbers Post FQ3 Report and Preannouncement
-
Canaccord Adams Initiates Coverage on MDRNA, Inc. (MRNA) with a Buy; One-Stop Shop for RNAi Technology
-
Canaccord Adams Reiterates a 'Sell' Rating on Nokia (NOK); Q1 Comes in Light; Estimates Reduced
-
Canaccord Adams Reiterates a 'Hold' on PDF Solutions (PDFS); Raises PT & Estimates
-
Canaccord Adams Maintains a 'Buy' on Local.com (LOCM); Strong Q1 Beat, Raising 2010 Guidance, Seeing Pickup in Ad Spend
-
Wall Street Can't Keep Up with Netflix (NFLX) Momentum
-
Canaccord Adams Sees Sustainability From Earth Day Companies
-
Canaccord Adams Maintains a 'Buy' on EnCana Corporation (ECA); Q1 Review
-
Notable Analyst Rating Changes 04/21: RPM, GET, VMW, MANH Upgraded; VITC, GILD, SNV, WFT Downgraded
-
Canaccord Adams Reiterates a 'Buy' Rating on Vascular Solutions (VASC); Solid Q1 Results
-
Canaccord Adams Reiterates a 'Buy' on Edwards Lifesciences (EW); Solid Q1 Results
-
Canaccord Adams Initiates Voverage on AVEO Pharmaceuticals (AVEO) with a Buy; Best-in-Class Cancer Drug Moves Forward
-
Canaccord Adams Reiterates a 'Buy' on Vocus (VOCS); Sequential Revenue Growth Sustained with Acquisitions
-
Canaccord Adams Reiterates a 'Hold' on Altera (ALTR); New Products and Industrial Drive Upside
-
Canaccord Adams Reiterates a 'Buy' on Apple Inc. (AAPL); Blow Out Quarter Driven by Record iPhone sales
-
KMG Chemicals (KMGB) Prices 1M Common Offering at $17.50/Share
-
FBR Research Offers Geographic Breakdown for Halliburton's (HAL) Q2
-
Atheros Communications (ATHR) Shares Up 8% On Positive Q1 Earnings Report; Brokers Reiterate 'Buy' Ratings
-
Canaccord Adams Maintains a 'Buy' on GLG Life Tech (GLGL); Comments From Road Show with CFO
